Updated: 2008-02-06
Contents
7.1 - RECALLS
7.1.1 - DEFINITIONS
7.1.1.1 - Recall
7.1.1.2 - Recall Classification
7.1.1.2.1 - Class I Recall
7.1.1.2.2 - Class II Recall
7.1.1.2.3 - Class III Recall
7.1.1.3 - Recall Type
7.1.1.4 - Recall Strategy
7.1.1.5 - Depth of Recall
7.1.1.6 - Recall Number
7.1.1.7 - Medical Device Notification Order
7.1.1.8 - Medical Device Notification
7.1.1.9 - Medical Device Safety Alert
7.1 - RECALLS
7.1.1 - DEFINITIONS
7.1.1.1 - Recall
A Recall is a firm's removal or correction of a marketed product that FDA considers to be in violation of the laws it administers, and against which the Agency would initiate legal action (e.g., seizure). Recall does not include a market withdrawal or a stock recovery. See the Agency recall policy outlined in 21 CFR 7.1/7.59 - Enforcement Policy - General Provisions, Recalls (Including Product Corrections) - Guidance on Policy, Procedures, and Industry Responsibilities.
7.1.1.2 - Recall Classification
Means the numerical designation, i.e., I, II, or III, assigned by the FDA to a particular product recall to indicate the relative degree of health hazard presented by the product being recalled.
7.1.1.2.1 - Class I Recall
A situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
7.1.1.2.2 - Class II Recall
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
7.1.1.2.3 - Class III Recall
A situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
7.1.1.3 - Recall Type
A designation based on whether the recall is Voluntary, FDA Requested (at the request of the Commissioner or his designee), or ordered under section 518(e) of the FD & C Act [21 U.S.C 360h (e)].
7.1.1.4 - Recall Strategy
A planned specific course of action to be taken in conducting a specific recall, which addresses the depth of recall, need for public warnings, and extent of effectiveness checks for the recall.
7.1.1.5 - Depth of Recall
Depending on the product's degree of hazard and extent of distribution, the recall strategy will specify the level in the distribution chain to which the recall is to extend, i.e., wholesaler, retailer, user/consumer.
7.1.1.6 - Recall Number
Number assigned by a responsible Center for each recalled product they initiate. This number consists first of a letter designating the responsible Center (see letter Codes below), a 3-digit sequential number indicating the number of recalls initiated by that Center during the fiscal year, and a 1-digit number (the Center for Devices and Radiological Health (CDRH) uses 2-digit numbers) indicating the fiscal year the recall was initiated. For example: F-100-2 identifies the 100th recall initiated by the Center for Food Safety and Applied Nutrition (CFSAN) in FY-2002. The following letters are used to identify the Centers. | Letter | Center/Office | | F | Foods - CFSAN | | D | Drugs - Center for Drug Evaluation and Research (CDER) | | Z | Medical Devices & Radiological Health - CDRH | | V | Veterinary Medicine - Center for Veterinary Medicine (CVM) | | B | Biologics - Center for Biologics Evaluation and Research (CBER) | | N | Medical Devices (Voluntary Safety Alerts & Notifications) | | A | Audit Numbers issued by the District performing the recall, the Centers, Office of Enforcement (Division of Compliance Management and Operations [DCMO], or the Division of Field Investigations (DFI) to monitor recalls requiring audit checks. |
7.1.1.7 - Medical Device Notification Order
An order issued by FDA requiring notification under section 518(a) of the FD & C Act [21 U.S.C. 360h (a)]. The directive issues when FDA determines a device in commercial distribution, and intended for human use, presents an unreasonable risk of substantial harm to the public health. The notification is necessary to eliminate the unreasonable risk of such harm, and no more practicable means is available under the provisions of the Act to eliminate such risk.
7.1.1.8 - Medical Device Notification
A communication issued by the manufacturer, distributor, or other responsible person in compliance with a Notification Order. It notifies health professionals and other appropriate persons of an unreasonable risk of substantial harm to the public health presented by a device in commercial distribution.
7.1.1.9 - Medical Device Safety Alert
This is a communication voluntarily issued by a manufacturer, distributor, or other responsible person (including FDA). It informs health professionals and other appropriate persons of a situation which may present an unreasonable risk to the public health by a device in commercial distribution.
NOTE: Medical Device Notifications and Safety Alerts as described in IOM 7.1.1.7, 7.1.1.8, and 7.1.1.9 are to be handled by the Districts as recalls. They will go through the stages of alert, recommendation, classification, field notification, firm notification letter, firm effectiveness checks and status reports, FDA audit checks, and termination recommendations.
|
